OLPA’s Gray Retires After More Than 3 Decades
|Roz Gray (at right, and center, above) was feted at her recent retirement party by OLPA director Pat White (l) and NIAID director Dr. Anthony Fauci.
Roz Gray, deputy director of the Office of Legislative Policy and Analysis for more than a decade, retired at the end of December 2012 after more than 30 years at NIH. She had also served as acting OLPA director for several extended periods.
A graduate of Virginia State University, Gray was a microbiologist by training. Prior to joining NIH, she worked as quality control manager for a subsidiary of the Reynolds Metals Co. in Richmond, group leader of analytical microbiology for Beecham Pharmaceuticals in Piscataway, N.J., and as a research chemist for Hoffmann-LaRoche Pharmaceuticals in Nutley, N.J.
Gray graduated from the NIH Management Intern Program then joined NIH’s legislative office. She worked to educate Congress about the research conducted by NIH-supported scientists, focusing on such issues as HIV/AIDS, infectious diseases, vaccines and, more recently, pandemic influenza, biodefense, biosafety and diversity issues.
As an NIH legislative specialist at the beginning of the AIDS epidemic, she was a key player as NIH and the Public Health Service began to wrestle with this global threat. Gray also took pride in serving as a mentor to NIH interns, fellows and OLPA employees and has served on many NIH committees.
Gray’s OLPA colleagues held a retirement party for her in Wilson Hall on Jan. 29. Paying tribute to her were NIH director Dr. Francis Collins, NIAID director Dr. Anthony Fauci, Office of AIDS Research director Dr. Jack Whitescarver and former Office of Research on Women’s Health director Dr. Vivian Pinn. Moreover, Sen. Barbara Mikulski (D-MD) honored Gray in the Congressional Record for her many achievements in advancing the mission of NIH.
NIGMS Fills Two Scientific Slots
Two scientists recently joined NIGMS in key positions.
Dr. Alison Hall is deputy director of the Division of Training, Workforce Development and Diversity, which supports the institute’s research training, career development, diversity and capacity-building activities through a number of programs at the undergraduate, graduate, postdoctoral, faculty and institutional levels. She joins NIGMS from Case Western Reserve University School of Medicine. There, she was a professor in the department of neurosciences and associate dean of graduate education.
Hall earned a bachelor’s degree in biochemistry and cell biology from the University of California, San Diego, and a Ph.D. in developmental genetics and anatomy/neuroscience from Case Western Reserve University School of Medicine, where she also conducted postdoctoral research.
Dr. Darren Sledjeski is chief of the Genetic Mechanisms Branch in the Division of Genetics and Developmental Biology, where he also administers research grants in the areas of transcription mechanisms and symbiotic relationships and community ecology. He was formerly a challenge manager and scientific initiatives manager in the NIAID Office of Initiative Development. Prior to that, Sledjeski was a scientific review officer in the institute’s Office of Scientific Review.
Sledjeski came to NIH from the University of Toledo Medical Center, where he was first an assistant and later an associate professor in the department of microbiology and immunology. He earned a bachelor’s degree in biology from the College of William and Mary and a Ph.D. in microbiology from the University of Maryland. Sledjeski conducted postdoctoral research at NCI.
Cooper To Direct CSR’s Division of Receipt and Referral
The Center for Scientific Review has named Dr. Cathleen Cooper as director of its Division of Receipt and Referral. She has served as acting director of DRR since September 2012, and previously served as a review group chief as well as a scientific review officer and a referral officer.
“Dr. Cooper is a proven manager with a profound appreciation of the NIH peer review and referral systems,” said CSR director Dr. Richard Nakamura. “She also has excelled in working with the scientific community in positive ways during difficult times.”
Cooper has been at CSR for 12 years. She earned a Ph.D. in pathology at the University of Southern California, where she studied naturally occurring delayed-type hypersensitivity reactions to mycobacteria. She did her postdoctoral training in molecular immunology at Columbia University then went to the University of Massachusetts Medical School as an assistant professor in the department of cell biology and the cancer center. There, she led a research team studying the molecular regulation of early events in hematopoietic development with special emphasis on B lymphocyte and neutrophil differentiation.